| Therapeutic versatility of resveratrol derivatives W Nawaz, Z Zhou, S Deng, X Ma, X Ma, C Li, X Shu Nutrients 9 (11), 1188, 2017 | 147 | 2017 |
| Antioxidant therapy for management of oxidative stress induced hypertension KA Ahmad, D Yuan Yuan, W Nawaz, H Ze, CX Zhuo, B Talal, A Taleb, ... Free radical research 51 (4), 428-438, 2017 | 132 | 2017 |
| The emerging roles of human trace amines and human trace amine-associated receptors (hTAARs) in central nervous system. MZ Khan, W Nawaz Biomedicine & Pharmacotherapy= Biomedecine & Pharmacotherapie 83, 439-449, 2016 | 95 | 2016 |
| Glycoside-based niosomal nanocarrier for enhanced in-vivo performance of Cefixime M Imran, MR Shah, F Ullah, S Ullah, AMA Elhissi, W Nawaz, F Ahmad, ... International Journal of Pharmaceutics 505 (1-2), 122-132, 2016 | 76 | 2016 |
| A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration X Wu, L Cheng, M Fu, B Huang, L Zhu, S Xu, H Shi, D Zhang, H Yuan, ... Cell reports 37 (3), 2021 | 73 | 2021 |
| AAV-mediated in vivo CAR gene therapy for targeting human T-cell leukemia W Nawaz, B Huang, S Xu, Y Li, L Zhu, H Yiqiao, Z Wu, X Wu Blood cancer journal 11 (6), 119, 2021 | 62 | 2021 |
| Sugar-based novel niosomal nanocarrier system for enhanced oral bioavailability of levofloxacin M Imran, MR Shah, F Ullah, S Ullah, AMA Elhissi, W Nawaz, F Ahmad, ... Drug Delivery 23 (9), 3653-3664, 2016 | 51 | 2016 |
| Nanotechnology and immunoengineering: How nanotechnology can boost CAR-T therapy W Nawaz, S Xu, Y Li, B Huang, X Wu, Z Wu Acta Biomaterialia 109, 21-36, 2020 | 43 | 2020 |
| Double-tailed acyl glycoside niosomal nanocarrier for enhanced oral bioavailability of Cefixime M Imran, MR Shah, F Ullah, S Ullah, A Sadiq, I Ali, F Ahmed, W Nawaz Artificial cells, nanomedicine, and biotechnology 45 (7), 1440-1451, 2017 | 35 | 2017 |
| A single-domain antibody inhibits SFTSV and mitigates virus-induced pathogenesis in vivo X Wu, Y Li, B Huang, X Ma, L Zhu, N Zheng, S Xu, W Nawaz, C Xu, Z Wu JCI insight 5 (13), 2020 | 32 | 2020 |
| Gingerol activates noxious cold ion channel TRPA1 in gastrointestinal tract Y Meng-Qi, YE Lin-Lan, LIU Xiao-Ling, QI Xiao-Ming, LV Jia-Di, W Gang, ... Chinese journal of natural medicines 14 (6), 434-440, 2016 | 28 | 2016 |
| A novel mouse model of chronic prostatitis/chronic pelvic pain syndrome induced by immunization of special peptide fragment with aluminum hydroxide adjuvant FU Khan, AU Ihsan, W Nawaz, MZ Khan, M Yang, G Wang, X Liao, L Han, ... Immunology Letters 187, 61-67, 2017 | 24 | 2017 |
| Establishment of a rat model of chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) induced by immunization with a novel peptide T2 AU Ihsan, FU Khan, W Nawaz, MZ Khan, M Yang, X Zhou Biomedicine & Pharmacotherapy 91, 687-692, 2017 | 21 | 2017 |
| Infection of humanized mice with a novel phlebovirus presented pathogenic features of severe fever with thrombocytopenia syndrome S Xu, N Jiang, W Nawaz, B Liu, F Zhang, Y Liu, X Wu, Z Wu PLoS Pathogens 17 (5), e1009587, 2021 | 20 | 2021 |
| Chitosan-coated rectangular DNA nanospheres for better outcomes of anti-diabetic drug MMFA Baig, M Naveed, M Abbas, SA Kassim, GJ Khan, S Ullah, M Sohail, ... Journal of Nanoparticle Research 21, 1-14, 2019 | 17 | 2019 |
| Short-term instantaneous prophylaxis and efficient treatment against SARS-CoV-2 in hACE2 mice conferred by an intranasal nanobody (Nb22) X Wu, Y Wang, L Cheng, F Ni, L Zhu, S Ma, B Huang, M Ji, H Hu, Y Li, ... Frontiers in immunology 13, 865401, 2022 | 13 | 2022 |
| Evaluation of chitosan/eudragit hybrid coating over cubic DNA nanospheres with superior stability and therapeutic outcomes MMFA Baig, M Naveed, M Abbas, SA Kassim, M Sohail, S Ullah, ... Journal of Drug Delivery Science and Technology 52, 577-585, 2019 | 12 | 2019 |
| Exo-organoplasty interventions: A brief review of past, present and future directions for advance heart failure management W Nawaz, FU Khan, MZ Khan, W Gang, M Yang, X Liao, L Zhang, ... Biomedicine & Pharmacotherapy 88, 162-172, 2017 | 12 | 2017 |
| Induction of neutralizing antibodies by human papillomavirus vaccine generated in mammalian cells X Wu, X Ma, Y Li, Y Xu, N Zheng, S Xu, W Nawaz, Z Wu Antibody therapeutics 2 (2), 45-53, 2019 | 9 | 2019 |
| The potential roles of interleukin-25 in infectious diseases J Wu, F Zhang, H Tao, W Nawaz, D Chen, Z Wu Frontiers in Immunology 13, 986118, 2022 | 7 | 2022 |
